Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology

NCT03940846 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.

NCT NCT03940846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03940846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology
Lead sponsor
Maastricht University
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2019
Completion date
January 31, 2021
Enrollment
650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonsmall cell lung cancer